Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
about
Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-HA randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma.Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab.
P2860
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@ast
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@en
type
label
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@ast
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@en
prefLabel
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@ast
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@en
P2093
P2860
P1433
P1476
Phase II study of a salvage re ...... B-cell non-Hodgkin's lymphoma.
@en
P2093
Akane Tsujimura
Ako Kikuchi
Aya Oshiro
Harumi Kato
Hirofumi Taji
Kazuhito Yamamoto
Michinori Ogura
Yasuhiro Oki
Yasuo Morishima
Yoshitoyo Kagami
P2860
P304
P356
10.1111/J.1349-7006.2007.00662.X
P577
2007-11-07T00:00:00Z